Cardiol Therapeutics Inc Class A (CRDL)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $127.69M
Last updated: Nov 17, 2026 at 11:04 AM ET
Cardiol Therapeutics Inc Class A (CRDL) Competitors
The companies most similar to Cardiol Therapeutics Inc Class A are Akebia Ther (AKBA), Cumberland Pharmaceuticals (CPIX) and Lifecore Biomedical (LFCR). By market cap, Cardiol Therapeutics Inc Class A ranks 7th of the 13 companies on this page; Tilray (TLRY) is the largest at $359.12M.
Peer Comparison
CRDL's revenue growth of 0.0% is above the peer median of -9.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Cardiol Therapeutics Inc Class A (CRDL) | $127.69M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Akebia Ther (AKBA) | $131.67M | N/A | 0.6x | -22.6% | -38.9% | -37.2% | 0.00% |
| Cumberland Pharmaceuticals Inc (CPIX) | $88.16M | N/A | 3.1x | 148.6% | N/A | -74.0% | 28.79% |
| Lifecore Biomedical Inc. (LFCR) | $243.36M | N/A | N/A | -66.8% | N/A | -18.6% | 0.00% |
| Journey Medical Corp (DERM) | $122.24M | N/A | 1.5x | -7.3% | -2.8% | 7.6% | 0.00% |
| Anika Therapeutics Inc (ANIK) | $179.50M | 18.7x | 1.4x | -1.4% | N/A | 10.0% | 0.00% |
| Organogenesis Holdings Inc (ORGO) | $105.15M | N/A | 0.3x | -38.5% | -66.3% | -69.9% | 0.00% |
| OrganiGram Holdings Inc (OGI) | $116.93M | N/A | 0.4x | 28.0% | -1.2% | 49.4% | 0.00% |
| SIGA Technologies Inc (SIGA) | $196.88M | 475.0x | N/A | 1.3% | N/A | -49.7% | 0.00% |
| Tilray Inc (TLRY) | $359.12M | N/A | 0.3x | -17.1% | -4.9% | 22.7% | 0.00% |
| Talphera Inc. (TLPH) | $47.07M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| BioAge Labs, Inc (BIOA) | $255.03M | N/A | 27.9x | 0.0% | N/A | -85.5% | 0.00% |
| InterCure Ltd. (INCR) | $49.17M | N/A | N/A | -13.2% | N/A | 23.9% | 0.00% |
| Peer median | $126.95M | 246.9x | 1.0x | -4.4% | -4.9% | -9.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to Cardiol Therapeutics Inc Class A, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.
| Company | About | Peers |
|---|---|---|
| Akebia Ther (AKBA) | Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease. | AKBA competitors |
| Cumberland Pharmaceuticals Inc (CPIX) | Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development... | CPIX competitors |
| Lifecore Biomedical Inc. (LFCR) | Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally. | LFCR competitors |
| Journey Medical Corp (DERM) | Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States. | DERM competitors |
| Anika Therapeutics Inc (ANIK) | Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. | ANIK competitors |
| Organogenesis Holdings Inc (ORGO) | Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports... | ORGO competitors |
| OrganiGram Holdings Inc (OGI) | Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada. | OGI competitors |
| SIGA Technologies Inc (SIGA) | SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States. | SIGA competitors |
| Tilray Inc (TLRY) | Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. | TLRY competitors |
| Talphera Inc. (TLPH) | Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs. | TLPH competitors |
| BioAge Labs, Inc (BIOA) | BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United... | BIOA competitors |
| InterCure Ltd. (INCR) | Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries... |
Frequently Asked Questions About CRDL
Who are Cardiol Therapeutics Inc Class A's main competitors?
The companies most similar to Cardiol Therapeutics Inc Class A include Akebia Ther (AKBA), Cumberland Pharmaceuticals (CPIX), Lifecore Biomedical (LFCR), Journey Medical (DERM) and Anika Therapeutics (ANIK), listed from the closest match.
Who is Cardiol Therapeutics Inc Class A's biggest competitor?
Tilray (TLRY) is the largest of the similar companies at $359.12M; Akebia Ther (AKBA) is the closest match by business profile, size, sector and industry.
How does CRDL stock compare with its competitors?
CRDL's net margin is 0.0% against a peer median of -4.4%.
Which of Cardiol Therapeutics Inc Class A's competitors pays a higher dividend?
Cardiol Therapeutics Inc Class A pays no dividend. Cumberland Pharmaceuticals (CPIX) has a higher forward dividend yield; Cumberland Pharmaceuticals (CPIX) has the highest at 28.79%.
Is Cardiol Therapeutics Inc Class A bigger than its competitors?
No. Cardiol Therapeutics Inc Class A is 7th by market cap among the 13 companies on this page; the largest is Tilray (TLRY) at $359.12M.
CRDL pages: Overview, Financials, Competitors